Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)

被引:1
|
作者
Autio, Karen A.
Anand, Aseem
Krupa, Rachel
Louw, Jessica
Arslan, Zaina
Dittamore, Ryan
Scher, Howard I.
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Epic Sci Inc, La Jolla, CA USA
关键词
D O I
10.1200/jco.2014.32.4_suppl.198
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
198
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Evaluation of clinical phenotype, survival, and circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC).
    Bitting, Rhonda Lynn
    Healy, Patrick
    Halabi, Susan
    George, Daniel J.
    Ko, Jung Hyun
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC)
    Gupta, Santosh
    Halabi, Susan
    Kemeny, Gabor
    Anand, Monika
    Nanus, David M.
    Giannakakou, Paraskevi
    George, Daniel J.
    Gregory, Simon
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [43] Molecular characterization of circulating tumor cells (CTC) and CTC. subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC)
    Dittamore, Ryan
    Louw, Jessica
    Krupa, Rachel
    Danila, Daniel Costin
    Arslan, Zaina
    Schreiber, Nicole A.
    Bales, Natalee
    Marrinucci, Dena
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Noninvasive measurement of prostate-specific membrane antigen (PSMA) expression with radiolabeled J591 imaging: A prognostic tool for metastatic castration-resistant prostate cancer (CRPC)
    Tagawa, Scott T.
    Akhtar, Naveed Hassan
    Christos, Paul J.
    Osborne, Joseph
    Vallabhajosula, Shankar
    Freedy, Shoaib
    Goldsmith, Stanley J.
    Nanus, David M.
    Bander, Neil Harrison
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Chromosomal instability (CIN) biomarker in circulating tumor cells (CTC) may predict for therapy resistance in metastatic castration-resistant prostate cancer (mCRPC)
    Keegan, N. M.
    Schonhoft, J.
    Barnett, E.
    Cohn, E. D.
    Zhao, J. L.
    Carbone, E. A.
    Zanone, M. R.
    Anderson, A.
    Wenstrup, R.
    Scher, H. I.
    ANNALS OF ONCOLOGY, 2021, 32 : S653 - S653
  • [46] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Bilusic, Marijo
    Karzai, Fatima
    Cordes, Lisa M.
    Strauss, Julius
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Karzai, Fatima
    Cordes, Lisa M.
    Schlom, Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [48] Long-term adverse events (AE) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving prostate-specific membrane antigen (PSMA)-based targeted radionuclide therapy (TRT).
    Sun, Michael
    Thomas, Charlene
    Ho, Benedict
    Niaz, Muhammad Junaid
    Molina, Ana M.
    Sternberg, Cora N.
    Nanus, David M.
    Bander, Neil Harrison
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) EXPRESSION AND PROSTATE CANCER SURVIVAL
    Kasperzyk, Julie
    Finn, Stephen
    Hendrickson, Whitney
    Flavin, Richard
    Fiorentino, Michelangelo
    Giovannucci, Edward
    Stampfer, Meir
    Loda, Massimo
    Mucci, Lorelei
    ANTICANCER RESEARCH, 2010, 30 (04) : 1535 - 1536
  • [50] Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells
    Kranzbuhler, Benedikt
    Salemi, Souzan
    Umbricht, Christoph A.
    Mueller, Cristina
    Burger, Irene A.
    Sulser, Tullio
    Eberli, Daniel
    PROSTATE, 2018, 78 (10): : 758 - 765